Pathogenetic mechanisms of atopic dermatitis

Archivum Immunologiae et Therapiae Experimentalis

Volumn 48, Issue 6, 2000, Pages 497-504

  Pastore, Saveria ^a   Mascia, Francesca ^a   Giustizieri, Maria Laura ^a   Giannetti, Alberto ^b   Girolomoni, Giampiero ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Atopy; Dendritic cells; Keratinocytes; Skin; T lymphocytes

Indexed keywords

ALLERGEN; AUTACOID; CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN E RECEPTOR; IRRITANT AGENT;

ATOPIC DERMATITIS; BIOSYNTHESIS; DENDRITIC CELL; EOSINOPHIL; GENOTYPE; HUMAN; IMMUNOLOGY; KERATINOCYTE; LIPID METABOLISM; MAST CELL; METABOLISM; PATHOLOGY; PHENOTYPE; REVIEW;

ALLERGENS; CHEMOKINES; CYTOKINES; DENDRITIC CELLS; DERMATITIS, ATOPIC; EOSINOPHILS; GENOTYPE; HUMANS; INFLAMMATION MEDIATORS; IRRITANTS; KERATINOCYTES; LIPID METABOLISM; MAST CELLS; PHENOTYPE; RECEPTORS, IGE;

EID: 0034569170     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. 4 counter-regulation by CLA-memory T cells. J. Immunol., 159, 4611-4619.
2. BARNES K. C. and MARSH D. G. (1998): The genetics and complexity of allergy and asthma. Immunol. Today, 19, 325-332.
3. BORRES M. P., ODELRAM H., IRANDER K., KJELLMAN N. I. and BJORKSTEN B. (1995): Peripheral blood eosinophilia in infants at 3 months of age is associated with subsequent development of atopic disease in early childhood. J. Allergy Clin. Immunol., 95, 694-698.
4. BRATTON D. L., HAMID Q., BOGUNIEWICZ M., DOHERTY D. E., KAILEY J. M. and LEUNG D. Y. M. (1995): Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis. J. Clin. Invest., 95, 211-218.
5. COLEMAN R., TREMBATH R. C. and HARPER J. I. (1997): Genetic studies of atopy and atopic dermatitis. Br. J. Dermatol., 136, 1-5.
6. COOPER K. D. (1994): Atopic dermatitis: recent trends in pathogenesis and therapy. J. Invest. Dermatol., 102, 128-137.
7. COX H. E., MOFFATT M. F., FAUX J. A., WALLEY A. J., COLEMAN R., TREMBATH R. C., COOKSON W. O. and HARPER J. I. (1998): Association of atopic dermatitis to the beta subunit of the high affinity immunoglobulin E receptor. Br. J. Dermatol., 138, 182-187.
8. DAUD L. R., GARRALDA M. E. and DAVID T. J. (1993): Psychosocial adjustment in preschool children with atopic eczema. Arch. Dis. Child., 69, 670-676.
9. DE SAINT-VIS B., FUGIER-VIVIER I., MASSACRIER C., GAILLARD C., VANBERVLIET B. and Aït-YAHIA S. (1998): The cytokine profile expressed by human dendritic cels is dependent on cell subtype and mode of activation. J. Immunol., 160, 1666-1676.
10. DE VRIES J. E. and PUNNONEN J. (1993): Regulation of human IgE response by IL-4 and IL-13. Res. Immunol., 144, 597-601.
11. FINLAY A. Y. and KHAN G. K. (1994): The dermatology life quality index: a simple practical measure for routine clinical use. Clin. Exp. Dermatol., 19, 210-216.
12. GREWE M., BRUIJNZEEL-KOOMEN C. A. F. M., SCHÖPF E., THEPEN T., LANGEVELD-WILDSCHUT A. G., RUZICKA T. and KRUTMANN J. (1998): A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol. Today, 19, 359-361.
13. HAMID Q., BOGUNIEWICZ M. and LEUNG D. Y. M. (1994): Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J. Clin. Invest., 94, 870-876.
14. HOFER M. F., HARBECK R. J., SCHLIEVERT P. M. and LEUNG D. Y. M. (1999): Staphylococcal toxins augment specific IgE responses by atopic patients exposed to allergen. J. Invest. Dermatol., 112, 171-176.
15. HOPKIN J. M. (1997): Mechanisms of enhanced prevalence of asthma and atopy in developed countries. Curr. Opin. Immunol., 9, 788-792.
16. HORSMANHEIMO L., HARVIMA I. T., JÄRVIKALLIO A., HARVIMA R. J., NAUKKARINEN A. and HORSMANHEIMO M. (1994): Mast cells are one major source of IL-4 in atopic dermatitis. Br. J. Dermatol., 131, 348-353.
17. IRANI A. M., SAMPSON H. A. and SCHWARTZ L. B. (1989): Mast cells in atopic dermatitis. Allergy, 44, (suppl. 9), 31-34.
18. JONES M. J. and MURRAY A. W. D. (1995): Evidence that ceramide selectively inhibits protein kinase C-alpha translocation and modulates bradykinin activation of phospholipase D. J. Biol. Chem., 270, 5007-5013.
19. JURGHANS V., GUTGESELL C., JUNG T. and NEUMANN C. (1998): Epidermal cytokines IL-1β, TNF-α, and IL-12 in patients with atopic dermatitis: response to application of house dust mite antigens. J. Invest. Dermatol., 111, 1184-1188.
20. KAPP A., CZECH W., KRUTMANN J. and SCHÖPF E. (1991): Eosinophil cationic protein in sera of patients with atopic dermatitis. J. Am. Acad. Dermatol., 24, 555-558.
21. KATAGIRI K., ITAMI S., HATANO Y and TAKAYASU S. (1997): Increased levels of IL-13 mRNA, but not IL-4 mRNA, are found in vivo in peripheral blood mononuclear cells of patients with atopic dermatitis. Clin. Exp. Immunol., 108, 389-394.
22. KHURANA-HERSHEY G. K., FRIEDRICH M. F., ESSWEIN L. A., THOMAS M. L. and CHATILA T. A. (1997): The association of atopy with a gain-of-function mutation in the α-subunit of the IL-4 receptor. N. Engl. J. Med., 337, 1721-1725.
23. KONDO H., ICHIKAWA Y. and IMOKAWA G. (1998): Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response. Eur. J. Immunol., 28, 769-779.
24. LEUNG D. Y. M. (1995): Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J. Allergy Clin. Immunol., 96, 302-319.
25. LEUNG D. Y. M. (1997): Atopic dermatitis: immunobiology and treatment with immune modulators. Clin. Exp. Immunol., 107 (suppl. 1), 25-30.
26. LEUNG D. Y. M., WOOD N., DUEEY D., RHODES A. R. and GEHA R. S. (1983): Cellular basis of defective cell-mediated lympholysis in atopic dermatitis. J. Immunol., 130, 1678-1682.
27. LEWIS-JONES M. S. and FINLAY A. Y. (1995): The children's dermatology life quality index (CDLQI): initial validation and practical use. Br. J. Dermatol., 132, 942-949.
28. MAO X. Q., SHIRAKAWA T., YOSHIKAWA T., KAWAI M., SASAKI S., ENOMOTO T., HASHIMOTO T., FURUYAMA J., HOPKIN J. M. and MORIMOTO K. (1996): Association between genetic variants of mast-cell chymase and eczema. Lancet, 348, 581-583.
29. MAREKOV L. N. and STEINERT P. M. (1998): Ceramides are bound to structural proteins of the human foreskin epidermal cornified cell envelope. J. Biol. Chem., 273, 17763-17770.
30. MAURER D., FIEBIGER S., EBNER C., REININGER B., FISCHER G. F., WICHLAS S., JOUVIN M. H., SCHMITT-EGENOLF M., KRAFT D., KINET J.-P. and STINGL G. (1996): Peripheral blood dendritic cells express FceRI as a complex composed of FcεRI α and FcεRIγ chains and can use this receptor for IgE-mediated allergen presentation. J. Immunol., 157, 607-616.
31. MCCOY J. P., HANLEY-YANEZ K., MCCASLIN D. and THARP M. D. (1992): Deletion of decreased cytotoxic effector CD8+ T lymphocytes in atopic dermatitis by flow cytometry. J. Allergy Clin. Immunol., 90, 688-690.
32. MOCHIZUKI M., BARTELS J., MALLET A. I., CHRISTOPHERS E. and SCHROEDER J.-M. (1998): Interleukin 4 induces eotaxin: a possible mechanism of selective eosinophil recruitmentin helminth infection and atopy. J. Immunol., 160, 60-68.
33. MURATA Y., OGATA J., HIGAKI Y., KAWASHIMA M., YADA Y., HIGUCHI K., TSUCHIYA T., KAWAINAMI S. and IMOKAWA G. (1996): Abnormal expression of sphingomyelin-acylase in atopic dermatitis: an etiologic factor for ceramide deficiency? J. Invest. Dermatol., 106, 1242-1249.
34. NISHIZUKA Y. (1992): Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science, 258, 607-614.
35. OHMEN J. D., HANIFIN J. M., NICKOLOFF B. J., REA T. H., WYZYKOWSKI R., KIM J., JULLIEN D., MCHUGH T., NASSIF A. S., CHAN S. C. and MODLIN R. L. (1995): Overexpression of IL-10 in atopic dermatitis. J. Immunol., 154, 1956-1963.
36. PAGANELLI R., FANALES-BELASIO E., CARMINI D., SCALA E., MEGLIO P., BUSINCO L. and AIUTI F. (1991): Serum eosinophil cationic protein in patients with atopic dermatitis. Int. Arch. Allergy Appl. Immunol., 96, 175-178.
37. PASTORE S., CAVANI A. and GIROLOMONI G. (1996): Epidermal cytokine and neuronal modulation of contact hypersensitivity reactions. Immunopharmacology, 31, 117-130.
38. PASTORE S., CORINTI S., LA PLACA M., DIDONA B. and GIROLOMONI G. (1998): Interferon-γ promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitis. J. Allergy Clin. Immunol., 101, 538-544.
39. PASTORE S., FANALES-BELASIO E., ALBANESI C., CHINNI L. M., GIANNETTI A. and GIROLOMONI G. (1997): Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. J. Clin. Invest, 99, 3009-3017.
40. PETERING H., HÖCHSTETTER R., KIMMING D., SMOLARSKI R., KAPP A. and ELSNER J. (1998): Detection of MCP-4 in dermal fibroblasts and its activation of the respiratory burst in human eosinophils. J. Immunol., 160, 555-558.
41. RING J., DARSOW U., GFESSER M. and VIELUF D. (1997): The "atopy patch test" in evaluating the role of aeroallergens in atopic eczema. Int. Arch. Allergy Immunol., 113, 379-383.
42. ROUSSET F., ROBERT J., ANDARY M., BONNIN J. P., SOUILLET G., CHRÉTIEN I., BRIERE F., PENE J. and DE VRIES J. E. (1991): Shifts in IL-4 and IFN-γ production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis. J. Allergy Clin. Immunol., 87, 58-69.
43. RUDIKOFF D. and LEBWOHL M. (1998): Atopic dermatitis. Lancet, 351, 1715-1721.
44. RYSTEDT I. (1985): Hand eczema and long-term prognosis in atopic dermatitis. Acta Derm. Venereol., 117, 1-59.
45. SALLUSTO F., LANZAVECCHIA A. and MACKAY C. R. (1998): Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol. Today, 19, 568-574.
46. SCHÄFER T. and RING J. (1997): Epidemiology of allergic diseases. Allergy, 5 (suppl. 38), 14-22.
47. SEGUCHI T., CHANG-YI C., KUSUDA S., TAKAHASHI M., AISU K. and TEZUKA T. (1996): Decreased expression of filaggrin in atopic skin. Arch. Dermatol. Res., 288, 442-446.
48. STRICKLAND I., HAUK P. J., TRUMBLE A. E., PICKER L. J. and LEUNG D. Y. M. (1999): Evidence for superantigen involvement in skin homing of T cells in atopic dermatitis. J. Invest Dermatol., 112, 249-253.
49. nd Edition. CRC Press, Boca Raton, FL, 498-507.
50. VAN DER PLOEG I., JEDDI TERANI M., MATUSEVICIENE G., WAHLGREN C. F., FRANSSON J. and SCHEYNIUS A. (1997): Interleukin 13 overexpression in skin is not confined to IgE-mediated skin inflammation. Clin. Exp. Immunol., 109, 526-532.
51. WEDI B., RAAP U. and KAPP A. (1997): Delayed eosinophil programmed cell death in vitro: a common feature of inhalant allergy and extrinsic and intrinsic atopic dermatitis. J. Allergy Clin. Immunol., 97, 536-543.
52. WILLIAMS H., ROBERTSON C., STEWART A., Aït-KHALED N., ANABWANI G., ANDERSON R., SHER I., BEASLEY R., BJORKSTEN B., BURR M., CLAYTON T., CRANE J., ELLWOOD P., KEIL U., LAI C., MALLOL J., MARTINEZ F., MITCHELL E., MANTEFORT S., PEARCE N., SHAH J., SIBBALD B., STRACHAN D., VON MUTIUS E. and WEILAND S. K. (1999): Worldwide variations in the prevalence of atopic eczema in the international study of asthma and allergies in childhood. J. Allergy Clin. Immunol., 103, 125-138.
53. WOLLENBERG A., KRAFT S., HANAU D. and BIEBER T. (1996): Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cells (IDEC) population in lesional skin of atopic eczema. J. Invest. Dermatol., 106, 446-453.
54. WOOD L. C., ELIAS P. M., CALHOUN C., TSAI J. C., GRUNFELD C. and FEINGOLD K. R. (1996): Barrier disruption stimulates interleukin-1α expression and release from a pre-formed pool in murine epidermis. J. Invest. Dermatol., 106, 397-403.
55. YING S., TABORDA-BARATA L., MENG Q., HUMBERT M. and KAY A. B. (1995): The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macrophage recruitment. J. Exp. Med., 181, 2153-2159.